Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity

v3.10.0.1
Stockholders' Equity
6 Months Ended
Jun. 30, 2018
Equity [Abstract]  
Stockholders' Equity

9. Stockholders’ Equity

 

Shares issued

 

On June 18, 2018, the Company completed a public offering of 10,085,500 shares of its common stock, at the price of $2.85 per share, for gross proceeds of $28.7 million. After the payment of underwriter discounts and offering expenses the Company received net proceeds of approximately $26.6 million.

 

1,072,500 shares of common stock were issued during January 2018 upon exercise of the overallotment option related to the December 2017 public offering, netting proceeds to the Company of $2.1 million.

 

The Company issued 65,600 shares of common stock upon vesting of Restricted Stock Units during the six months ended June 30, 2018. Additionally, the Company issued 2,034 shares of common stock pursuant to the Officers and Directors Purchase Plan during the six months ended June 30, 2018 for proceeds of $4,000.

 

Warrant modification

 

On June 24, 2018, the Company entered into a series of agreements (see Note 10 for details) with Interstate Battery, which modified the terms of a warrant to purchase 702,247 shares of our common stock by reducing the exercise price of the warrant from $7.12 per share to $3.33 per share and extended the expiration date of the warrant from June 24, 2018 to June 23, 2020. The expiration date had previously been extended from May 2018 to June 2018 as part of the overall negotiations. The incremental fair value resulting from this modification was calculated to be $1.0 million using the Black-Scholes-Merton Option Pricing Model with the assumptions as follows: $3.26 per share fair value on the date of modification; 2-year term; 80.2% volatility; 2.56% discount rate and 0% annual dividend rate.

 

The Company previously recorded $0.6 million in general and administrative expense during the year ended December 31, 2017 with the offset in accrued liabilities as an estimate of this liability. Upon modification, the Company recorded an additional $0.4 million in general and administrative expense for the three months ended June 30, 2018, relieved $0.6 million in accrued liabilities with the $1.0 million offset to additional paid-in capital.

 

Stock-based compensation

 

The stock-based compensation expense attributable to option grants was allocated as follows:

 

    Three months ended June 30,     Six months ended June 30,  
    2018     2017     2018     2017  
Cost of product sales   $ 47     $ 24     $ 97     $ 24  
Research and development cost     77       73       189       160  
General and administrative expense     224       209       206       283  
Total   $ 348     $ 306     $ 492     $ 467  

 

The following assumptions were used in the Black-Scholes-Merton pricing model to estimate the fair value of options granted during the periods presented.

 

    Three months ended June 30,     Six months ended June 30,  
    2018     2017     2018     2017  
                         
Expected stock volatility     79.5%-86.3 %     71.0%-72.7 %     78.4%-86.3 %     70.9%-72.7 %
Risk free interest rate     2.4%-2.8 %     1.4%-1.7 %     2.1%-2.8 %     1.4%-1.8 %
Expected years until exercise     2.5 - 3.5       2.5 - 3.5       2.5 - 3.5       2.5 - 3.5  
Dividend yield     0 %     0 %     0 %     0 %

 

There were no stock option exercises during the three and six months ended June 30, 2018.

 

Stock option issuances

 

In connection with his appointment as President of the Company in May 2018, Stephen Cotton was awarded options to purchase up to 840,000 shares of the Company’s common stock. Options to purchase 420,000 common shares are exercisable over a five-year period at an exercise price of $3.00 per share. Options to purchase 210,000 common shares are exercisable over a five-year period at an exercise price of $5.00 per share and options to purchase 210,000 common shares are exercisable over a five-year period at an exercise price of $7.00 per share. The options vest in 1/36th increments during each of the first twelve months following the date of grant and thereafter the options vest in one-third increments on the second and third anniversary of the date of grant. The options issued are subject to the terms and conditions of the Company’s Amended and Restated 2014 Stock Incentive Plan (“2014 Plan) but were not issued under the 2014 Plan in reliance on with Nasdaq Rule 5635(c)(4) and therefore do not reduce the number of shares available under the 2014 Plan.

 

Stock option modification

 

In connection with his termination, the stock options of our former CEO were modified to extend the exercise period upon termination from 90 days to 2 years. The expense related to the modification of these stock option awards was approximately $15,000.

 

Restricted Stock Units

 

In April 2018, the Company granted 150,000 restricted stock units (RSUs) with a grant fair value of $339,000 to its Chief Financial Officer, Francis Knuettel II, as part of his employment agreement. The RSUs vest as follows: 50,000 RSUs shall vest on April 12, 2019 and, thereafter, 4,167 RSUs shall vest on a monthly basis over the next 24 months. The RSUs are subject to the terms and conditions of our Amended and Restated 2014 Stock Incentive Plan. If at any time prior to April 12, 2019 Mr. Knuettel II is terminated without Cause or resigns for Good Reason, then the 50,000 RSUs that would otherwise vest on April 12, 2019 shall vest immediately and be included as severance.